919 Spam-Free Article(s) Found
||Teva Pharmaceutical Industries Limited
May 22, 2017 - Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
Sep 13, 2017 - Dupixent's phase 3 trials in asthma were a success, clearing the way to an FDA filing this year in this multibillion-dollar indication.
Sep 17, 2018 - A new migraine drug is a big win amid the turnaround of generics business.
Apr 22, 2017 - High dividend yields for CenturyLink, GlaxoSmithKline, and Teva look great, but there's more to the story for these stocks.
Sep 09, 2017 - Find out what's behind the drops for these companies.
Sep 17, 2018 - Names on the move ahead of the open.
Jul 06, 2017 -
On CNBC's "Fast Money Halftime Report", Jon Najarian said that options traders were buying call options in Energy Transfer Equity LP (NYSE: ETE) in the first half of the trading session on Wednesd
Sep 12, 2018 - Names on the move ahead of the open.
Jun 12, 2017 - Teva Pharmaceutical Industries Ltd. said Monday it has launched a generic version of the cholesterol lowering medication Zetia.
Zetia, which contains the active ingredient ezetimibe, is a prescription medicine made by Merck (NYSE: MRK) used to lower levels of total cholesterol and low-density lipoprotein (LDL) cholesterol in the blood. Ezetimibe tablets are for patients who cannot control their cholesterol levels by diet and exercise alone. Teva said the product can be used by itself or with other…
Aug 04, 2017 -
Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ: TEVA) shares are trading lower $2.00 (8 percent) at $21.75 in Friday's session. That comes on top of Thursday's loss of $7.50, or 24 percent.